Caballero Martínez Mª Victoria, Porras Gallo María Isabel
Facultad de Medicina de Ciudad Real; Universidad de Castilla-La Mancha. Ciudad Real. España.
Rev Esp Salud Publica. 2025 Apr 9;99:e202504020.
The epidemic emergence of poliomyelitis in Europe at the end of the 19 century and its global epidemic progression in the following decades generated great social concern and prompted the international fight against the disease, especially after 1953, when the World Health Organization (WHO) considered it an important international Public Health problem. Spain recorded small outbreaks, which became more intense after the Spanish Civil War and, particularly after 1950. In the middle of that decade, the first vaccines became available in the USA and Europe, and became the main tools to control polio. In Spain, Florencio Pérez Gallardo, from the National School of Public Health, led the work to study the magnitude of the disease and produce his own vaccine, for which he required international support. Within the framework of the social history of medicine, and using varied sources, our work places the Spanish vaccination strategy in the European context, highlighting the delay in its initiation and the deficiencies in its materialization. In addition, it analyses the role played by the international research stays of Pérez Gallardo and his team in order to overcome some limitations and, in 1963, to carry out the first national immunization campaign with Sabin vaccine, packaged by IBYS laboratories, showing the weight carried by their international relations, particularly with Albert Sabin.
19世纪末脊髓灰质炎在欧洲的流行出现,以及随后几十年在全球范围内的流行发展引起了极大的社会关注,并促使国际社会展开对抗该疾病的斗争,尤其是在1953年之后,当时世界卫生组织(WHO)将其视为一个重要的国际公共卫生问题。西班牙记录了小规模的疫情爆发,在内战后疫情变得更加严重,特别是在1950年之后。在那十年中期,首批疫苗在美国和欧洲问世,并成为控制脊髓灰质炎的主要工具。在西班牙,来自国家公共卫生学院的弗洛伦西奥·佩雷斯·加拉尔多领导了研究该疾病规模并研发本国疫苗的工作,为此他需要国际支持。在医学社会史的框架内,并利用各种资料来源,我们的研究将西班牙的疫苗接种策略置于欧洲背景下,突出其启动的延迟以及实施过程中的不足。此外,它分析了佩雷斯·加拉尔多及其团队的国际研究访问所发挥的作用,以克服一些限制,并在1963年开展了首次使用由IBYS实验室包装的萨宾疫苗的全国免疫运动,展示了他们国际关系的影响力,特别是与阿尔伯特·萨宾的关系。